Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 36: 1444-1449, 1990;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christenson, R. H.
Right arrow Articles by Wagner, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christenson, R. H.
Right arrow Articles by Wagner, G. S.

Clinical Chemistry, Vol 36, 1444-1449, Copyright © 1990 by American Association for Clinical Chemistry

Relative increase in creatine kinase MB isoenzyme during reperfusion after myocardial infarction is method dependent

RH Christenson, P Clemmensen, EM Ohman, J Toffaletti, LM Silverman, P Grande, RT Vollmer and GS Wagner
Department of Laboratory Service, Durham Veterans Administration Medical Center, NC 27705.

We compared relative increases in creatine kinase (EC 2.7.3.2) MB isoenzyme (CK-MB) after reperfusion in myocardial infarction for four popular methods: electrophoresis, immunoinhibition, the "Magic Lite" (Ciba-Corning) system, and the Stratus (Dade). In a method comparison study, we confirmed that all four methods correlated (r greater than 0.95). Electrophoresis demonstrated the greatest scatter about the regression line, immunoinhibition the least. For CK-MB quantities near each method's "positive cutoff" indicating myocardial infarction, results by all methods agreed in 95% of samples. To characterize relative increases in CK-MB, we computer-fitted data obtained from each method for serial specimens collected from six acute myocardial infarction patients during myocardial reperfusion. Although for each individual patient the four methods appeared to exhibit parallelism, the methods differed significantly in terms describing their appearance rate, peak-time & fall-off, and time-to-peak activity. Consistent with these data, we found that the relative CK-MB increases at various times after reperfusion, compared with baseline concentrations, are method- dependent. Therefore, when using CK-MB for indicating coronary patency, one must develop specific limits for each method utilized.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
R. H. Christenson and H. M. E. Azzazy
Biochemical markers of the acute coronary syndromes
Clin. Chem., August 1, 1998; 44(8): 1855 - 1864.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. H. Christenson, S.-H. Duh, L. K. Newby, E. M. Ohman, R. M. Califf, C. B. Granger, S. Peck, K. S. Pieper, P. W. Armstrong, H. A. Katus, et al.
Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes
Clin. Chem., March 1, 1998; 44(3): 494 - 501.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
R. H. Christenson, E. M. Ohman, E. J. Topol, S. Peck, L. K. Newby, S.-H. Duh, D. J. Kereiakes, S. J. Worley, G. L. Alosozana, T. C. Wall, et al.
Assessment of Coronary Reperfusion After Thrombolysis With a Model Combining Myoglobin, Creatine Kinase–MB, and Clinical Variables
Circulation, September 16, 1997; 96(6): 1776 - 1782.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Association for Clinical Chemistry.